Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Direct oral anticoagulants for postoperative myocardial injury

Myocardial injury after non-cardiac surgery (MINS), detected by elevated troponin measurement, is a common postoperative complication and increases the risk of 30-day mortality by three times.1 In The Lancet, P J Devereaux and colleagues2 report the results of the MANAGE trial, a randomised, placebo-controlled study investigating use of the direct oral anticoagulant dabigatran in 1754 patients with MINS. Eligible patients were aged at least 45 years, had undergone non-cardiac surgery, and were within 35 days of MINS.